Global Choroideremia Treatment Market, By Therapy Type (Dorzolamide, Topical Carbonic Anhydrase Inhibitor, Luxturna (voretigene neparvovec-rzyl), Gene Therapy, Antioxidants, Lutein),Route of Administration (Oral, Opthalmic, Intravenous),Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drugstores, Online Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028